BlackRock, Inc. 13D and 13G filings for Olema Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-29 5:25 pm Purchase | 2023-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA | BlackRock Inc. BLK | 3,263,907 6.000% | 1,958,403 (+150.01%) | Filing |
| 2022-07-08 4:57 pm Sale | 2022-06-30 | 13G | Olema Pharmaceuticals, Inc. OLMA | BlackRock Inc. BLK | 1,305,504 3.200% | -992,660 (-43.19%) | Filing |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA | BlackRock Inc. BLK | 2,298,164 5.700% | 2,298,164 (New Position) | Filing |